Inflammatory bowel disease research group

Marte Lie Høivik
Group leader

Our main focus is clinical epidemiology, biomarkers, prognostic research and patient-reported outcomes research within IBD (inflammatory bowel disease; Crohn’s disease and ulcerative colitis). We work with clinical quality registries and clinical effectiveness research, as well as registry and health economics research focusing on the introduction of new biological drugs in clinical practice locally, regionally and nationally.